Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats
Bisphosphonates (BPs) and teriparatide (TPTD) are both effective treatments for osteoporosis, but BP treatment prior to daily TPTD treatment has been shown to impair the effect of TPTD in some clinical studies. In contrast, the loss of bone mineral density (BMD) that occurs after withdrawal of TPTD...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-12-01
|
| Series: | Bone Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187217300177 |
| _version_ | 1811231595359633408 |
|---|---|
| author | T. Shimizu T. Tanaka T. Kobayashi I. Kudo M. Nakatsugawa A. Takakura R. Takao-Kawabata T. Ishizuya |
| author_facet | T. Shimizu T. Tanaka T. Kobayashi I. Kudo M. Nakatsugawa A. Takakura R. Takao-Kawabata T. Ishizuya |
| author_sort | T. Shimizu |
| collection | DOAJ |
| description | Bisphosphonates (BPs) and teriparatide (TPTD) are both effective treatments for osteoporosis, but BP treatment prior to daily TPTD treatment has been shown to impair the effect of TPTD in some clinical studies. In contrast, the loss of bone mineral density (BMD) that occurs after withdrawal of TPTD can be prevented by BP treatment. Although various studies have investigated the combination and/or sequential use of BP and TPTD, there have been no clinical studies investigating sequential treatment with zoledronic acid (ZOL) and TPTD (or vice versa). In this study, we evaluated the effects of sequential treatment with TPTD followed by ZOL, and ZOL followed by TPTD, using ovariectomized (OVX) rats.
Two months after OVX, osteopenic rats were treated with ZOL, TPTD, or vehicle for a period of 4 months (first treatment period), and then the treatments were switched and administered for another 4 months (second treatment period).
The group treated with ZOL followed by TPTD showed an immediate increase in BMD of the proximal tibia and greater BMD and bone strength of the lumbar vertebral body, femoral diaphysis, and proximal femur than the group treated with ZOL followed by vehicle. Serum osteocalcin, a marker of bone formation, increased rapidly after switching to TPTD from ZOL.
The group treated with TPTD followed by ZOL did not lose BMD in the proximal tibia after TPTD was stopped, while the group treated with TPTD followed by vehicle did lose BMD. The BMD and bone strength of the lumbar vertebral body, femoral diaphysis, and proximal femur were greater in the group treated with TPTD followed by ZOL than in the group treated with TPTD followed by vehicle. The increase in serum osteocalcin and urinary CTX after withdrawal of TPTD was prevented by the switch from TPTD to ZOL.
In conclusion, our results demonstrate that switching from ZOL to TPTD resulted in a non-attenuated anabolic response in the lumbar spine and femur of OVX rats. In addition, switching from TPTD to ZOL caused BMD to be maintained or further increased. If these results can be reproduced in a clinical setting, the sequential use of ZOL followed by TPTD or vice versa in the treatment of osteoporosis patients would contribute to increases in BMD that, hopefully, would translate into a corresponding decrease in the incidence of vertebral and non-vertebral fractures. |
| first_indexed | 2024-04-12T10:47:36Z |
| format | Article |
| id | doaj.art-356d023ab8004e5688e9ba601f77ed13 |
| institution | Directory Open Access Journal |
| issn | 2352-1872 |
| language | English |
| last_indexed | 2024-04-12T10:47:36Z |
| publishDate | 2017-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Bone Reports |
| spelling | doaj.art-356d023ab8004e5688e9ba601f77ed132022-12-22T03:36:21ZengElsevierBone Reports2352-18722017-12-017C708210.1016/j.bonr.2017.06.001Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized ratsT. ShimizuT. TanakaT. KobayashiI. KudoM. NakatsugawaA. TakakuraR. Takao-KawabataT. IshizuyaBisphosphonates (BPs) and teriparatide (TPTD) are both effective treatments for osteoporosis, but BP treatment prior to daily TPTD treatment has been shown to impair the effect of TPTD in some clinical studies. In contrast, the loss of bone mineral density (BMD) that occurs after withdrawal of TPTD can be prevented by BP treatment. Although various studies have investigated the combination and/or sequential use of BP and TPTD, there have been no clinical studies investigating sequential treatment with zoledronic acid (ZOL) and TPTD (or vice versa). In this study, we evaluated the effects of sequential treatment with TPTD followed by ZOL, and ZOL followed by TPTD, using ovariectomized (OVX) rats. Two months after OVX, osteopenic rats were treated with ZOL, TPTD, or vehicle for a period of 4 months (first treatment period), and then the treatments were switched and administered for another 4 months (second treatment period). The group treated with ZOL followed by TPTD showed an immediate increase in BMD of the proximal tibia and greater BMD and bone strength of the lumbar vertebral body, femoral diaphysis, and proximal femur than the group treated with ZOL followed by vehicle. Serum osteocalcin, a marker of bone formation, increased rapidly after switching to TPTD from ZOL. The group treated with TPTD followed by ZOL did not lose BMD in the proximal tibia after TPTD was stopped, while the group treated with TPTD followed by vehicle did lose BMD. The BMD and bone strength of the lumbar vertebral body, femoral diaphysis, and proximal femur were greater in the group treated with TPTD followed by ZOL than in the group treated with TPTD followed by vehicle. The increase in serum osteocalcin and urinary CTX after withdrawal of TPTD was prevented by the switch from TPTD to ZOL. In conclusion, our results demonstrate that switching from ZOL to TPTD resulted in a non-attenuated anabolic response in the lumbar spine and femur of OVX rats. In addition, switching from TPTD to ZOL caused BMD to be maintained or further increased. If these results can be reproduced in a clinical setting, the sequential use of ZOL followed by TPTD or vice versa in the treatment of osteoporosis patients would contribute to increases in BMD that, hopefully, would translate into a corresponding decrease in the incidence of vertebral and non-vertebral fractures.http://www.sciencedirect.com/science/article/pii/S2352187217300177Zoledronic acidTeriparatideSequential treatmentOvariectomized ratBone mineral densityBone metabolism |
| spellingShingle | T. Shimizu T. Tanaka T. Kobayashi I. Kudo M. Nakatsugawa A. Takakura R. Takao-Kawabata T. Ishizuya Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats Bone Reports Zoledronic acid Teriparatide Sequential treatment Ovariectomized rat Bone mineral density Bone metabolism |
| title | Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats |
| title_full | Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats |
| title_fullStr | Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats |
| title_full_unstemmed | Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats |
| title_short | Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats |
| title_sort | sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats |
| topic | Zoledronic acid Teriparatide Sequential treatment Ovariectomized rat Bone mineral density Bone metabolism |
| url | http://www.sciencedirect.com/science/article/pii/S2352187217300177 |
| work_keys_str_mv | AT tshimizu sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT ttanaka sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT tkobayashi sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT ikudo sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT mnakatsugawa sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT atakakura sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT rtakaokawabata sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats AT tishizuya sequentialtreatmentwithzoledronicacidfollowedbyteriparatideorviceversaincreasesbonemineraldensityandbonestrengthinovariectomizedrats |